Artificial Ventilation and Anesthesia Masks Market Analysis by Application (Operation Room, Intensive Care Units, Emergency Room, Dental, Home Care) by Risk of the Procedure (High, Moderate Risk, Standard Patients) and Segment Forecasts To 2022

Published: Jan, 2016 | Pages: 93 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

Global artificial ventilation and anesthesia masks market is expected to reach USD 2,888.8 million by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to market growth include rising number of operation and emergency room procedures coupled with growing demand novel products which can be used to carry out intubation process without removing the oxygen mask. Increase in the target disease has a direct impact on the number of operation room, emergency and intensive care procedures and is expected to boost usage rates of ventilation masks over the forecast period.

Increasing geriatric population is a major factor increasing the prevalence rate of several diseases. Additionally, growing prevalence of sleep apnea is one of the most significant growth drivers for these anesthesia and ventilation masks over the forecast period.

According to statistics published by the National Sleep Foundation in 2012, around 40 million Americans were affected by chronic sleep disorders. Furthermore, these patients are at a high risk of visiting emergency department and intensive care units, and as a consequence are expected to increase the demand of ventilation masks in the next seven years.

The market dynamics indicate that various players operating in this space compete on the basis of product specification and prices. The technology used to manufacture, quality of the product, and patient comfort are the key variables expected to impact the usage of these products. The healthcare providers assess the risk to the patient and determine the need to use invasive ventilation or non-invasive ventilation. The use of non invasive masks in accident and trauma cases, lung failure and other emergency cases is a key factor contributing to the high usage rates of these products.

The market is segmented on the basis of application as operation room, intensive care units, emergency room, dental, and home care. In 2014 operating room held the maximum share of over 58% for low risk procedures and is expected to be the largest segment in the next seven years. Increase in insurance penetration, number of hospitals and dental centers to tap the high unmet needs in emerging economies is a key factor expected to boost the surgical volume and therefore these factors are expected to increase the demand for ventilation masks over the forecast period.

Further key findings from the report suggest:

In 2014, North America dominated the overall market with a share of more than 50%. Key factors attributing to its large share include presence of robust healthcare infrastructure, which includes hospitals, emergency and dental centers.

Furthermore, in the U.S., the Affordable Care Act is a key driver encouraging millions of patients to opt for surgical treatments and utilize other healthcare services, and as a result is expected to boost usage rates of artificial ventilation and anesthesia masks over the forecast period.

Asia Pacific is expected to be the fastest growing market over the forecast period. Key factors attributing to its high growth are increase in public and private healthcare expenditure to build new hospitals, improve reimbursement scenario which lead to improvement in overall healthcare indicators.

Additionally, large population affected with various diseases is expected to increase the number of emergency, ICU and operating room procedures and as a result are expected to increase usage rates in these markets.

Key players operating in the market include Phillips Respironics, ResMed, Fisher & Paykel, CareFusion, Ambu, Drager, and others. These companies have an extensive portfolio of ventilation and CPAP masks.

Additionally, emergence of new players with novel product offerings such as SuperNO2VA from RMDevices is expected change market dynamics due to its ability to carry out inhalation anesthesia, artificial ventilation and intubation procedure simultaneously.

 Table of Contents


Chapter 1 Methodology and Scope
                  1.1 Research Methodology
                  1.2 Research Scope & Assumptions
                  1.3 List of Data Sources
Chapter 3 Artificial Ventilation and Anesthesia Masks Industry Outlook
                  3.1 Market segmentation
                  3.2 Artificial ventilation and anesthesia masks market dynamics
                  3.3 Market driver analysis
                     3.3.1 Rising prevalence of respiratory disorders
                     3.3.2 Growing prevalence of sleep apnea
                     3.3.3 Increasing prevalence of sleep apnea in co-morbidities
                     3.3.4 Increasing geriatric population
                  3.4 Market restraint analysis
                  3.5 Lack of Patient Compliance
                  3.6 Key Opportunities Prioritized
                  3.7 Industry analysis - Porter's
                  3.8 Artificial ventilation and anesthesia masks market PESTEL Analysis
                  3.9 Opportunity Analysis
                  3.10 Company market share analysis, 2014
Chapter 4 Application Outlook
                  4.1 Artificial ventilation and anesthesia masks market share by application, 2014 & 2022
                  4.2 Operation Room
                     4.2.1 Operation room market estimates and forecasts, 2012-2022
                  4.3 Intensive Care Units
                     4.3.1 Intensive care unit market estimates and forecasts, 2012-2022
                  4.4 Emergency Room
                     4.4.1 Emergency room market estimates and forecasts, 2012-2022
                  4.5 Dental
                     4.5.1 Dental market estimates and forecasts, 2012-2022
                  4.6 Home Care
                     4.6.1 Home care market estimates and forecasts, 2012-2022
Chapter 5 Artificial Ventilation and Anesthesia Masks Regional Outlook
                  5.1 Artificial ventilation and anesthesia masks market share, by region, 2014 & 2022
                  5.2 North America
                     5.2.1 North America artificial ventilation and anesthesia masks market estimates and forecasts, high risk procedures, 2012 - 2022 (USD Million)
                     5.2.2 North America artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 - 2022(USD Million)
                     5.2.3 North America artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 - 2022(USD Million)
                  5.3 U.S.
                     5.3.1 Number of registered hospitals in the U.S.
                     5.3.2 Total number of in-patient surgeries in the U.S., 2010.
                     5.3.3 U.S. artificial ventilation and anesthesia masks market estimates and forecasts, high risk procedures, 2012 - 2022(USD Million)
                     5.3.4 U.S. artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 - 2022(USD Million)
                     5.3.5 U.S. artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 - 2022(USD Million)
                  5.4 Canada
                     5.4.1 Canada top five reasons for in-patient hospitalization, 2012-2013
                     5.4.2 Top five reasons for in-patient surgeries in Canada, 2012-2013
                     5.4.3 Canada artificial ventilation and anesthesia masks market estimates and forecasts, high risk procedures, 2012 - 2022(USD Million)
                     5.4.4 Canada artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 - 2022(USD Million)
                     5.4.5 Europe artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 - 2022(USD Million)
                  5.5 Europe
                     5.5.1 Europe artificial ventilation and anesthesia masks market estimates and forecasts, high risk procedures, 2012 - 2022(USD Million)
                     5.5.2 Europe artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 - 2022(USD Million)
                     5.5.3 Europe artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 - 2022(USD Million)
                  5.6 Germany
                     5.6.1 Germany artificial ventilation and anesthesia masks market estimates and forecasts, high risk procedures, 2012 - 2022(USD Million)
                     5.6.2 Germany artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 - 2022(USD Million)
                     5.6.3 Germany artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 - 2022(USD Million)
                  5.7 UK
                     5.7.1 UK artificial ventilation and anesthesia masks market estimates and forecasts, high risk procedures, 2012 - 2022(USD Million)
                     5.7.2 UK artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 - 2022(USD Million)
                     5.7.3 UK artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 - 2022(USD Million)
                  5.8 Asia Pacific
                     5.8.1 Asia Pacific artificial ventilation and anesthesia masks market estimates and forecasts, high risk procedures, 2012 - 2022(USD Million)
                     5.8.2 Asia Pacific artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 - 2022(USD Million)
                     5.8.3 Asia Pacific artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 - 2022(USD Million)
                  5.9 China
                     5.9.1 China artificial ventilation and anesthesia masks market estimates and forecasts, high risk procedures, 2012 - 2022(USD Million)
                     5.9.2 China artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 - 2022(USD Million)
                     5.9.3 China artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 - 2022(USD Million)
                  5.10 India
                     5.10.1 India artificial ventilation and anesthesia masks market estimates and forecasts, high risk procedures, 2012 - 2022(USD Million)
                     5.10.2 India artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 - 2022(USD Million)
                     5.10.3 India artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 - 2022(USD Million)
                  5.11 RoW
                     5.11.1 RoW artificial ventilation and anesthesia masks market estimates and forecasts, high risk procedures, 2012 - 2022(USD Million)
                     5.11.2 RoW artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 - 2022(USD Million)
                     5.11.3 RoW artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 - 2022(USD Million)
                  5.12 Brazil
                     5.12.1 Brazil artificial ventilation and anesthesia masks market estimates and forecasts, high risk procedures, 2012 - 2022(USD Million)
                     5.12.2 Brazil artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 - 2022(USD Million)
                     5.12.3 Brazil artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 - 2022(USD Million)
                  5.8 South Africa
                     5.13.1 South Africa artificial ventilation and anesthesia masks market estimates and forecasts, high risk procedures, 2012 - 2022(USD Million)
                     5.13.2 South Africa artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 - 2022(USD Million)
                     5.13.3 South Africa artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 - 2022(USD Million)
Chapter 6 Competitive Landscape
                  6.1 CareFusion
                     6.1.1 Company Overview
                     6.1.2 Financial Performance
                     6.1.3 Product Benchmarking
                     6.1.4 Strategic Initiatives
                  6.2 Air Liquide Healthcare
                     6.2.1 Company Overview
                     6.2.2 Financial Performance
                     6.2.3 Product Benchmarking
                     6.2.4 Strategic Initiatives
                  6.3 Fisher & Paykel Healthcare
                     6.3.1 Company Overview
                     6.3.2 Financial Performance
                     6.3.3 Product Benchmarking
                     6.3.4 Strategic Initiatives
                     6.3.5 ASPs, 2014
                  6.4 HOFFRICHTER GmbH
                     6.4.1 Company Overview
                     6.4.2 Financial Performance
                     6.4.3 Product Benchmarking
                     6.4.4 Strategic Initiatives
                  6.5 Drager
                     6.5.1 Company Overview
                     6.5.2 Financial Performance
                     6.5.3 Product Benchmarking
                     6.5.4 Strategic Initiatives
                  6.6 Phillips
                     6.6.1 Company Overview
                     6.6.2 Financial Performance
                     6.6.3 Product Benchmarking
                     6.6.4 Strategic Initiatives
                     6.6.5 ASPs, 2014
                  6.7 ResMed
                     6.7.1 Company Overview
                     6.7.2 Financial Performance
                     6.7.3 Product Benchmarking
                     6.7.4 Strategic Initiatives
                     6.7.5 ASPs, 2014
                  6.8 Ambu
                     6.8.1 Company Overview
                     6.8.2 Financial Performance
                     6.8.3 Product Benchmarking
                     6.8.4 Strategic Initiatives
                  6.9 Acutronic Medical Systems
                     6.9.1 Company Overview
                     6.9.2 Financial Performance
                     6.9.3 Product Benchmarking
                     6.9.4 Strategic Initiatives
                  6.10 GaleMed
                     6.10.1 Company Overview
                     6.10.2 Financial Performance
                     6.10.3 Product Benchmarking
                     6.10.4 Strategic Initiatives

List of Tables


TABLE 1 Artificial ventilation and anesthesia masks market - Industry Summary & Key Buying Criteria, 2012 - 2022
TABLE 2 Global artificial ventilation and anesthesia masks market, by application, for high risk procedures, 2012 - 2022 (USD Million)
TABLE 3 Global artificial ventilation and anesthesia masks market, by application, for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 4 Global artificial ventilation and anesthesia masks market, by application, for standard patients, 2012 - 2022 (USD Million)
TABLE 5 Artificial ventilation and anesthesia masks market, by region, for high risk procedures, 2012 - 2022 (USD Million)
TABLE 6 Artificial ventilation and anesthesia masks market, by region, for high risk procedures, 2012 - 2022 (USD Million)
TABLE 7 Artificial ventilation and anesthesia masks market, by region, for high risk procedures, 2012 - 2022 (USD Million)
TABLE 8 Market size and growth prospects, for high risk procedures, 2012 - 2022
TABLE 9 Market size and growth prospects, for moderate risk procedure, 2012 - 2022
TABLE 10 Market size and growth prospects, standard patients, 2012 - 2022
TABLE 11 Artificial ventilation and anesthesia masks market - Key market driver analysis
TABLE 12 North America geriatric population (Over 60 Years) (Million) (2012-2022)
TABLE 13 Europe geriatric population (Over 60 Years) (Million) (2012-2022)
TABLE 14 Asia geriatric population (Over 60 Years) (Million) (2012-2022)
TABLE 15 Latin America geriatric population (Over 60 Years) (Million) (2012-2022)
TABLE 16 Africa geriatric population (Over 60 Years)(Million) (2012-2022)
TABLE 17 Artificial ventilation and anesthesia masks market - Key market restraint analysis
TABLE 18 Common conditions and procedures with the highest proportion of intensive care (ICU) utilization in 29 states, 2011.
TABLE 19 North America artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 20 North America artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million) 
TABLE 21 North America artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million) 
TABLE 22 U.S. artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million) 
TABLE 23 U.S. artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 24 U.S. artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million) 
TABLE 25 Canada artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million) 
TABLE 26 Canada artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)n
TABLE 27 Canada artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 28 Europe artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million) 
TABLE 29 Europe artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 30 Europe artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 31 Germany artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million) 
TABLE 32 Germany artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 33 Germany artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 34 UK artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million) 
TABLE 35 UK artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 36 UK artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 37 Asia Pacific artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million) 
TABLE 38 Asia Pacific artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 39 Asia Pacific artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 40 China artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million) 
TABLE 41 China artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 42 China artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 43 India artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 44 India artificial ventilation and anesthesia masks for moderate risk procedures, 2012-2022, USD Million
TABLE 45 India artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 46 RoW artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 47 RoW artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 48 RoW artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 49 Brazil artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 50 Brazil artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 51 Brazil artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 52 South Africa artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 53 South Africa artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 54 South Africa artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)